RD

Ronald A. DePinho

DI Dana-Farber Cancer Institute: 12 patents #56 of 1,343Top 5%
University Of Texas System: 2 patents #1,567 of 6,559Top 25%
UA University Of Arkansas: 2 patents #68 of 445Top 20%
The General Hospital: 1 patents #1,411 of 3,021Top 50%
GE Geron: 1 patents #93 of 147Top 65%
BC Beth Israel Deaconess Medical Center: 1 patents #325 of 672Top 50%
AP Aveo Pharmaceuticals: 1 patents #45 of 65Top 70%
📍 Houston, TX: #750 of 21,073 inventorsTop 4%
🗺 Texas: #5,391 of 125,132 inventorsTop 5%
Overall (All Time): #173,993 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
10378060 ZNF365/ZFP365 biomarker predictive of anti-cancer response Ji Hye Paik 2019-08-13
10363261 Enolase inhibitors and methods of treatment therewith Florian MULLER, David Maxwell, William Bornmann, Yu-Hsi Lin, Basvoju A. Bhanu Prasad +6 more 2019-07-30
9745631 Methods for diagnosing and treating oncogenic kras-associated cancer Lewis C. Cantley, Alec C. Kimmelman, Haoqiang Ying, Costas Lyssiotis 2017-08-29
9687548 Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof Xin Lu, Sarit Agasti, Ralph Weissleder 2017-06-27
9632090 Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours Ji Hye Paik, Ramya Kollipara 2017-04-25
9458510 Signatures and determinants associated with prostate cancer progression and methods of use thereof Zhihu Ding, Chang-Jiun Wu, Lynda Chin 2016-10-04
9452182 Collateral gene inactivation biomarkers and targets for cancer therapy Florian MULLER, Eliot Fletcher-Sananikone, Simona Colla, Elisa Aquilanti 2016-09-27
9309564 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer Kenneth C. Anderson, Ruben Carrasco, Giovanni Tonon, Cameron Brennan, John D. Shaughnessy +1 more 2016-04-12
8999633 Compositions, kits, and methods for identification, assessment, prevention and treatment of pancreatic adenocarcinoma in humans Lynda Chin, Cameron Brennan, Andrew J. Aguirre 2015-04-07
8211634 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer Kenneth C. Anderson, Ruben Carrasco, Giovanni Tonon, Cameron Brennan, John D. Shaughnessy +1 more 2012-07-03
8168602 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer Giovanni Tonon, Kwok-Kin Wong, Lynda Chin 2012-05-01
7622630 Chimeric cancer models Joerg Heyer, Murray Robinson, William Rideout, Steven C. Clark, Yinghui Zhou +2 more 2009-11-24
7595158 Bcl2L12 polypeptide activators and inhibitors Alex Stegh, Hyung Gee Kim, Lynda Chin 2009-09-29
7371515 Identifying and characterizing genes Lynda Chin 2008-05-13
6897197 Method of inhibiting cell proliferation using an anti-oncogene protein 2005-05-24
6767719 Mouse telomerase reverse transcriptase Gregg B. Morin, Richard Allsopp, Roger A. Greenberg 2004-07-27
6680371 Myc homology region II-associated protein and uses thereof 2004-01-20
6639121 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo Lynda Chin 2003-10-28
6613750 Method of inhibiting cell proliferation using an anti-oncogene protein 2003-09-02
6297368 Myc homology region II--associated protein and uses thereof 2001-10-02
6140476 Rep-max protein having anti-oncogenic activity and uses thereof Nicole Schreiber-Agus 2000-10-31
6040425 Myc homology region II--associated protein 2000-03-21
5919997 Transgenic mice having modified cell-cycle regulation David H. Beach, Manuel Serrano 1999-07-06
5811298 Rep-max protein having anti-oncogenic activity and uses thereof Nicole Schreiber-Agus 1998-09-22